atezolizumab,bevacizumab
roche
['bevacizumab', 'atezo', 'platinum', 'atalante', 'ovarian']
#esmo22:the addition of the pd-l1 inhibitor atezolizumab to chemotherapy plus bevacizumab showed little or no benefit in the relapsed setting in relapsed platinum-sensitive #ovariancancer: the atalante/ov29 trial 
The European Society for Medical Oncology (ESMO) is the leading organisation for cancer education and information, supporting the oncology community’s work.